Market pressures continue to change the focus and structure of the drug development industry with a heavy emphasis on accelerating early phases of development. The journey is long, and rarely is the path to the patient a straight line.
With this in mind, Charles River has built a team of talented Scientific Advisors whose purpose is to guide clients, every step of the way. With decades of industry experience and a proven ability to navigate a complex regulatory landscape, our Scientific Advisors design and manage lean yet robust nonclinical programs that reduce risk and accelerate timelines.
Providing flexible, responsive, and personalized service, we value every partner, every project, as if it were our own.
Customized program and study designs
Risk mitigation tactics
Contact our team about your project »
With access to the industry’s most comprehensive portfolio – from early discovery to market support – our team is uniquely qualified to map your journey through drug development.
- Our collaborative approach and deep scientific and regulatory understanding of each molecule provide you with the best strategy for bringing a novel therapy to market.